Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA review

The RESIST source identifies a 2% BHA leave-on treatment within an aging-skin-focused range. It is a distinct formula from CLEAR and Skin Perfecting products with similar salicylic acid headlines.

The range name describes positioning rather than a diagnosis. Compare the supporting ingredients and the reason for choosing an additional leave-on exfoliant. A mature-skin reader may need to weigh dryness and comfort alongside pores, rather than assuming that the anti-aging range can never irritate.

Read the actual formulation

The product name or current brand description states 2% salicylic acid or BHA; verify the applicable product label. The practical comparison is the leave-on bha treatment format, disclosed active ingredients and directions for that exact leave-on product. Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA is listed as leave-on bha treatment, so its ingredient story should stay attached to that category. When the source does not establish a concentration or a complete base, we leave that detail open rather than fill it from another product.

A useful way to assess this option is to compare it with a product performing the same job. For Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA, ask whether the attraction is the named active, the texture, the access route or a particular brand claim. Those reasons lead to different alternatives. A reader satisfied with an existing moisturizer may be choosing a treatment step; a reader mainly concerned about dryness may be deciding whether a separate serum adds anything useful.

The evidence question for this product

Salicylic acid belongs to the beta-hydroxy acid family. An acne drug label, a cosmetic exfoliant description and a body smoothing claim answer different questions. That context does not independently verify an outcome for Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA. The official source documents what its manufacturer or provider presents. The formulation-specific details above are useful for comparison, while a claim of better results would require evidence on the finished product and an appropriate comparator.

Routine fit and cautions

Adult acne can coexist with dry, sensitive skin. More exfoliation is not a reliable response to redness or persistent breakouts. With Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA, the relevant discussion includes the leave-on bha treatment format, disclosed active ingredients and directions for that exact leave-on product. Check the complete label and describe other leave-on products to a clinician if your skin is already irritated. A review cannot set a personal prescription schedule or identify the cause of a new skin change.

Compare the options in top 5 salicylic acid creams & treatments or read Creams versus liquids and gels.

Cost and the decision to buy

The source snapshot records $29.60 shown on the brand page. For Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA, confirm the actual selected size, quantity and purchase terms on the official page. Compare a retail bottle, a prescription supply and a consultation over the same period; their headline figures are not interchangeable. Subscription or bundle pricing is a separate purchase option, not a reason to assume that more products are necessary.

Our decision point is the leave-on bha treatment format, disclosed active ingredients and directions for that exact leave-on product. The information above helps decide what to read next and what needs clarification before purchasing Paula’s Choice RESIST Daily Pore-Refining Treatment 2% BHA. Use the related product review for a specific alternative and the category comparison to see the options together. If the ingredient identity, intended use or cost remains uncertain, the official manufacturer or treating clinician is the appropriate source for that missing detail.

Sources and verification

Official pages establish product facts and provider claims. Clinical and regulatory sources answer separate evidence questions. Checked October 1, 2026. No medical reviewer is credited for this article.